- Home
- JAGX vs LGHL Comparison
JAGX vs LGHL Comparison
Compare JAGX & LGHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAGX
- LGHL
- Stock Information
- Founded
- JAGX 2013
- LGHL 2015
- Country
- JAGX United States
- LGHL Singapore
- Employees
- JAGX N/A
- LGHL N/A
- Industry
- JAGX Biotechnology: Pharmaceutical Preparations
- LGHL Investment Bankers/Brokers/Service
- Sector
- JAGX Health Care
- LGHL Finance
- Exchange
- JAGX Nasdaq
- LGHL Nasdaq
- Market Cap
- JAGX 3.9M
- LGHL 4.4M
- IPO Year
- JAGX N/A
- LGHL N/A
- Fundamental
- Price
- JAGX $1.71
- LGHL $0.86
- Analyst Decision
- JAGX Strong Buy
- LGHL
- Analyst Count
- JAGX 1
- LGHL 0
- Target Price
- JAGX $60.00
- LGHL N/A
- AVG Volume (30 Days)
- JAGX 114.8K
- LGHL 149.6K
- Earning Date
- JAGX 11-14-2025
- LGHL 01-01-0001
- Dividend Yield
- JAGX N/A
- LGHL N/A
- EPS Growth
- JAGX N/A
- LGHL N/A
- EPS
- JAGX N/A
- LGHL N/A
- Revenue
- JAGX $11,810,000.00
- LGHL N/A
- Revenue This Year
- JAGX $22.41
- LGHL N/A
- Revenue Next Year
- JAGX $30.00
- LGHL N/A
- P/E Ratio
- JAGX N/A
- LGHL N/A
- Revenue Growth
- JAGX 15.96
- LGHL N/A
- 52 Week Low
- JAGX $1.57
- LGHL $0.71
- 52 Week High
- JAGX $33.25
- LGHL $16.40
- Technical
- Relative Strength Index (RSI)
- JAGX 36.00
- LGHL 35.56
- Support Level
- JAGX $1.77
- LGHL $0.71
- Resistance Level
- JAGX $2.00
- LGHL $1.18
- Average True Range (ATR)
- JAGX 0.13
- LGHL 0.10
- MACD
- JAGX -0.04
- LGHL -0.01
- Stochastic Oscillator
- JAGX 9.09
- LGHL 28.04
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
About LGHL Lion Group Holding Ltd.
Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.